Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa

Int J Antimicrob Agents. 2017 Jun;49(6):782-783. doi: 10.1016/j.ijantimicag.2017.04.001. Epub 2017 Apr 12.

¹ Infectious Disease Unit, Raymond Poincaré University Hospital, AP-HP, Versailles Saint-Quentin University, 104 Bd. R. Poincaré, F92380 Garches, France. Electronic address: aurelien.dinh@aphp.fr.
² Infectious Disease Unit, AP-HP, Bicêtre University Hospital, Kremlin-Bicêtre, France.
³ Infectious Disease Unit, AP-HP, Cochin University Hospital, Paris, France.
⁴ Clinical Microbiology Mobile Unit, Hôpital européen Georges-Pompidou, AP-HP, Paris Descartes University, Paris, France.
⁵ Pharmacy Department, Raymond Poincaré University Hospital, AP-HP, Versailles Saint-Quentin University, Garches, France.
⁶ Infectious Disease Unit, Raymond Poincaré University Hospital, AP-HP, Versailles Saint-Quentin University, 104 Bd. R. Poincaré, F92380 Garches, France.
⁷ Infectious Disease Unit, Poitiers University Hospital, Poitiers, France.
⁸ Pharmacy Department, Poitiers University Hospital, Poitiers, France.
⁹ Infectious Disease Unit, Nancy University Hospital, Nancy, France.
¹⁰ Infectious Disease Unit, Lyon University Hospital, Lyon, France.
¹¹ Intensive Care and Infectious Disease, AP-HP, Bichat University Hospital, Paris, France.

No abstract available

Publication types